COMMON STOCK PURCHASE WARRANT Celsion CorporationCelsion CORP • March 13th, 2020 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 10, 2020 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 10, 2025 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to [__________] shares of common stock, par value $0.01 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
AGREEMENT TO EXCHANGE WARRANTSCelsion CORP • March 13th, 2020 • Pharmaceutical preparations • New York
This is to record the agreement (the “Agreement”) between Celsion Corporation (the “Company”) and the Warrantholders set forth on Schedule I hereto (each a “Warrantholder” and collectively, the “Warrantholders”) regarding the terms on which the Company will issue Exchange Warrants (as defined below) to each Warrantholder in exchange for warrants originally issued pursuant to that Securities Purchase Agreement dated as of February 27, 2020 between the Company and each Warrantholder (the “Securities Purchase Agreement”), as applicable, to purchase shares of common stock and warrants to purchase shares of common stock of the Company. The original warrants were issued to the Warrantholders on March 3, 2020 (the “Original Warrants”). The Company and each Warrantholder hereby agree as follows:
